T cell therapy(University Of Erlangen-Nuremberg Medical School)

T细胞疗法（University Of Erlangen-Nuremberg Medical School）

Report date: 2022/07/04 19:38:02

Base Information

Drug NameT cell therapy(University Of Erlangen-Nuremberg Medical School)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsAutoimmune DiseasesColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Erlangen-Nuremberg Medical School
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Erlangen-Nuremberg Medical School
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A